English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background   Pegylated-interferon-α (peg-IFN-α) is the mainstay of treatment for chronic hepatitis C (CHC). Treatment is often complicated by neutropaenia due to inhibition of haematopoiesis. However, there are no data on the kinetics of granulocyte-colony stimulating factor (G-CSF), a major neutrophil growth factor, in this setting. We therefore evaluated G-CSF synthesis in CHC patients on peg-IFN-α treatment.Methods   A total of 40 CHC patients were studied. None had pre-existing haematological disorders, or hepatitis B virus or HIV coinfection. For controls, 30 healthy subjects were used. Laboratory examinations, including liver function tests, were performed at baseline and monthly over treatment and follow-up. Serum G-CSF was measured in all patients and controls at baseline and in a subgroup of 20 CHC patients also at weeks 2, 4, 24, 48 and 72 after treatment start.Results   CHC patients had a significantly lower pre-treatment neutrophil count (3,256 ±1,197 versus 3,804 ±859; P=0.03). Notwithstanding, they showed lower baseline G-CSF serum levels than healthy controls (16.1 ±6.2 versus 19.4 ±7.5; P=0.048). Consistently, baseline G-CSF levels were poorly correlated with the neutrophil count in CHC patients (r=-0.2; P=0.2). Moreover, serum G-CSF levels did not increase in any of the 20 CHC patients during peg-IFN-α treatment, despite declining neutrophil counts.Conclusions   The lower neutrophil counts observed in CHC might be related to an absolute deficiency in G-CSF production. In the human model of neutropaenia induced by peg-IFN-α, we show that endogenous G-CSF levels are not physiologically up-regulated to overcome the decline in neutrophil counts. Our study provides a rationale for the evaluation of recombinant human G-CSF treatment in peg-IFN-α-induced neutropaenia.

antiviral therapy

Defective Synthesis of Granulocyte-Colony Stimulating Factor in Pegylated Interferon-α Treated Chronic Hepatitis C Patients with Declining Leukocyte Counts